Early research (Phase 1)UnknownNCT04343859What this trial is testingIMMH-010 in Patients With Advanced Malignant Solid TumorsWho this might be right forMalignant Neoplasms Tianjin Chasesun Pharmaceutical Co., LTD 96
Testing effectiveness (Phase 2)Study completedNCT03425279What this trial is testingCAB-AXL-ADC Safety and Efficacy Study in Adult and Adolescent Patients With SarcomaWho this might be right forUndifferentiated Pleomorphic SarcomaMyxofibrosarcoma BioAtla, Inc. 245
Early research (Phase 1)UnknownNCT03932565What this trial is testingInterventional Therapy Sequential With the Fourth-generation CAR-T Targeting Nectin4/FAP for Malignant Solid TumorsWho this might be right forNectin4-positive Advanced Malignant Solid Tumor The Sixth Affiliated Hospital of Wenzhou Medical University 30
Testing effectiveness (Phase 2)Study completedNCT01567163What this trial is testingRamucirumab and Docetaxel in Participants With Solid TumorsWho this might be right forMalignant Solid Tumor Eli Lilly and Company 22
Not applicableNo Longer AvailableNCT01151930What this trial is testingLong-Term Compassionate Use Study for Continued Administration of SCB01A-01Who this might be right forMalignant Solid Tumour SynCore Biotechnology Co., Ltd.
Testing effectiveness (Phase 2)Study completedNCT03213691What this trial is testingSelumetinib Sulfate in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)Who this might be right forAdvanced Malignant Solid NeoplasmAnn Arbor Stage III Childhood Non-Hodgkin LymphomaAnn Arbor Stage IV Childhood Non-Hodgkin Lymphoma+8 more National Cancer Institute (NCI) 21
Early research (Phase 1)Ended earlyNCT04726332What this trial is testingStudy of XL102 as Single-Agent and Combination Therapy in Subjects With Solid Tumors (QUARTZ-101)Who this might be right forNeoplasm MalignantEpithelial Ovarian CancerTriple Negative Breast Cancer+2 more Exelixis 52
Early research (Phase 1)UnknownNCT05154604What this trial is testingSHR-A1921 for Injection in Subjects With Advanced Solid TumoursWho this might be right forAdvanced Solid Tumours Suzhou Suncadia Biopharmaceuticals Co., Ltd. 156
Early research (Phase 1)Study completedNCT00006464What this trial is testingUCN-01 and Cisplatin in Treating Patients With Advanced or Metastatic Solid TumorsWho this might be right forUnspecified Adult Solid Tumor, Protocol Specific City of Hope Medical Center
Testing effectiveness (Phase 2)WithdrawnNCT05582031What this trial is testingRegorafenib With Tislelizumab in Patients With Selected Mismatch Repair-Proficient/Microsatellite Stable CancersWho this might be right forAnal Squamous Cell CarcinomaColorectal NeoplasmsSoft Tissue Sarcoma+5 more Translational Research in Oncology
Testing effectiveness (Phase 2)Looking for participantsNCT06173219What this trial is testingSafety and Efficacy of Radiotherapy Combined with Immunotherapy for Advanced Malignant Tumors.Who this might be right forAdvanced Solid Tumor China-Japan Friendship Hospital 38
Early research (Phase 1)Not Yet RecruitingNCT07363369What this trial is testingExploratory Clinical Study of FAP mRNA Vaccine in Patients With Advanced Malignant Solid TumorsWho this might be right forAdvanced Malignant Solid Tumors West China Hospital 10
Early research (Phase 1)Ended earlyNCT05317078What this trial is testingSafety, Tolerability, and Pharmacokinetics Study of AMG 794 With Claudin 6-positive Non-small Cell Lung Cancer, Epithelial Ovarian Cancer, and Other Malignant Solid Tumor IndicationsWho this might be right forNon-squamous Non-small Cell Lung CancerEpithelial Ovarian CancerClaudin 6-positive Advanced/Metastatic Malignant Solid Tumors Amgen 3
Early research (Phase 1)Not Yet RecruitingNCT05783089What this trial is testingMSLN-targeted CAR-T Cells in Solid Tumors.Who this might be right forMesothelin-positive Advanced Malignant Solid Tumors Cancer Institute and Hospital, Chinese Academy of Medical Sciences 87
Early research (Phase 1)Not Yet RecruitingNCT05698238What this trial is testingClinical Study to Evaluate Safety and Dosing of CA9hu-1 in Patients With Advanced Solid TumoursWho this might be right forClear Cell Renal Cell Carcinoma MetastaticTNBC - Triple-Negative Breast CancerHead and Neck Cancer+2 more Mabpro, a.s. 50
Early research (Phase 1)Study completedNCT04991506What this trial is testingES102 (OX40 Agonist) in Combination With JS001 in Patients With Advanced Solid TumorsWho this might be right forSolid TumorNeoplasmsMalignant Tumor Elpiscience Biopharma, Ltd. 30
Early research (Phase 1)Looking for participantsNCT05477849What this trial is testingA Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biologic Effect of VG2025 in Patients with Solid TumorsWho this might be right forAdvanced Malignant Solid Tumor Shanghai Virogin Biotech Co., Ltd. 30
Early research (Phase 1)Looking for participantsNCT04678648What this trial is testingA Trial of RSC-1255 for Treatment of Patients With Advanced MalignanciesWho this might be right forAdvanced Malignant Solid NeoplasmRAS MutationLung Cancer+3 more RasCal Therapeutics, Inc. 134
Not applicableTemporarily pausedNCT05091632What this trial is testingAssessment of Verbal Comprehension and Cognitive Processes in Patients Admitted to the Palliative and Supportive Care UnitWho this might be right forHematopoietic and Lymphoid Cell NeoplasmLocally Advanced Malignant Solid NeoplasmMetastatic Malignant Solid Neoplasm+1 more M.D. Anderson Cancer Center 30
Early research (Phase 1)Study completedNCT00717704What this trial is testingSolid Tumors Using Ixabepilone and DasatinibWho this might be right forSolid Tumor Medstar Health Research Institute 19